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Background: Substance use disorder (SUD) is an important health problem that 
requires a complex range of care because of the chronic nature of the disorder and 
the multiple psychosocial problems involved. Current outpatient programs often have 
difficulties in delivering and coordinating ongoing care and access to different health-
care providers. Various case management (CM) models have been developed, first for 
patients in other psychiatric domains and then for patients with SUD, in order to improve 
treatment outcomes.
Aim: This paper aims to assess the effectiveness of CM for patients with SUD.
Methods: We performed a systematic review of CM interventions for patients with SUD 
by analyzing randomized controlled studies published on the subject between 1996 and 
2016 found on the electronic database PubMed.
Results and conclusion: Fourteen studies were included in the analysis. Differences 
between studies in outcome measures, populations included, and intervention charac-
teristics made it difficult to compare results. Most of these studies reported improvement 
in some of the chosen outcomes. Treatment adherence mostly improved, but substance 
use was reported to decrease in only a third of the studies. Overall functioning improved 
in about half of the studies. The heterogeneity of the results might be linked to these 
differences between studies. Further research is needed in the field.
Keywords: case management, assertive community treatment, substance use disorder, substance abuse, alcohol 
use disorder
inTRODUCTiOn
Substance use disorders (SUDs), which include drug abuse, problematic drug use, drug misuse, and 
substance misuse, are an important health problem (1). Persons with SUDs are characterized by 
multiple social and medical needs and are often known for their difficulty in engaging in treatment, 
partly because access to treatment facilities is limited (2). The chronicity and relapsing nature of SUD, 
as in other psychiatric disorders, entails frequent hospitalizations (3) and readmissions.
Patients presenting both severe mental illnesses and SUD are typically hospitalized more often than 
are non-substance users (4, 5). Patients presenting this double diagnosis also have more difficulties 
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entering alcohol and drug outpatient clinics than patients with 
only SUD (6). This group of patients seems to have less access 
to aftercare services (7) and higher use of acute services, such as 
emergency room treatment and hospital services (8).
The period after discharge is characterized by a high risk of 
relapse, with most cases occurring within the first week of inpa-
tient treatment (9). There is also an important risk of drug-related 
death (either accidental or intended) following a longer period 
of abstinence because of lower drug tolerance (10, 11). These 
patients have multiple psychosocial problems for which they need 
support. Patient needs often remain unmet in current outpatient 
treatment programs (2), although the provision of help with legal 
advice, basic needs, and family services may improve patients’ 
psychosocial functioning. Treatment continuity has been related 
to higher overall abstinence rates (12, 13) and less frequent read-
missions to hospital units (14). Between hospital and community 
care, treatment continuity is supposed to improve comprehensive 
support for patients.
Different strategies have been developed to improve treatment 
adherence and drug-related outcomes (15); among them, case 
management (CM) has been identified as potentially beneficial 
as suggested in early clinical studies (16). The definition of CM 
and its practice varies from place to place. In general, CM can be 
defined as a “coordinated integrated approach to service delivery, 
ongoing supportive care and help to access resources for living 
and functioning in the community” (17). This approach has been 
widely implemented in many different areas, such as insurance 
programs, education, and health care.
Given the complex, chronic, and relapsing nature of mental 
health disorders and SUDs, they require a broad and continuous 
approach such as can be offered by CM (17). Since the 1980s, this 
practice has been adapted for persons with SUD (18), but to date, 
only a few studies have described CM models for persons with 
SUD in Europe.
The aim of this study was thus to assess the effectiveness of 
CM for patients with SUD. We searched for published articles 
in which clinical CM was described for patients with SUD to 
help maintain treatment continuity and coordinate care after a 
patient was discharged from hospital or prison (transitional CM) 
or when a patient entered a treatment program.
MeTHOD
The electronic database PubMed was searched for empirical stud-
ies published between January 1996 and May 2016. The following 
keywords were used: “case management” AND “addiction”; “case 
management” AND “substance use disorder”; “case management” 
AND “substance abuse.” The inclusion criteria were as follows: 
randomized controlled trial, adult participants over the age of 
18 years with SUD, and a CM intervention compared to treatment 
as usual (TAU).
ReSULTS
After checking for the inclusion criteria and for duplicates, we 
analyzed 14 studies (Figure 1). Details about the included stud-
ies are described in Table 1. One paper (19) was reviewed but 
excluded. It compared assertive community treatment to another 
form of CM intervention. In absence of a TAU comparison group, 
the study was not included.
The names of CM interventions varied in different studies. 
They were labeled “intensive,” “community,” or “assertive CM” 
(20–22); “strengths-based” (23–26), “clinical” (27), and “tran-
sitional CM” (28); or “coordinated care management” (29) and 
“probation CM” (30). Although the names and interventions 
varied, certain common characteristics could be found. CM 
services were conducted by case managers with a professional 
background in nursing, social work, or mental health care (22). 
CM services were delivered mainly in the patients’ communities 
and not at the treatment center or hospital (20–22). The length of 
interventions varied from 1 month (25) to 3 years (20), although 
6 months to 1 year was the most common. The intensity of the 
CM intervention was rarely noted.
Study Populations
In some studies, the population had SUD and no further dif-
ferentiation was made, whereas other studies considered specific 
subgroups such as patients in methadone programs (27), women 
with SUD (22, 31, 32), and participants with court judgments 
who were either incarcerated or in court-ordered treatments (23, 
28, 30). Most studies were done in the United States, except for 
the one by Prendergast et al. (28) in Canada and Lindhal et al. 
(23) in Sweden.
Outcome Measures
The most frequently used outcome measures were change in drug 
or alcohol use, as well as adherence to SUD treatment (frequently 
measured in attendance rates) and linkage to other health-care 
providers. The other important outcome measures were health-
care use in terms of days of hospitalization, emergency ward 
visits, or health costs. On a more general level, some studies 
measured global functioning; employment rates; reduction of 
social, legal, and family problems; and client satisfaction. Two 
studies concerning incarcerated or court-ordered individuals 
also used the number of post-enrollment arrests as an outcome 
measure (28, 30).
Most studies considered only SUD as an inclusion criterion. 
Surprisingly, the importance of comorbid mental health disor-
ders or high service use was not defined as an inclusion criterion 
in most studies. Slesnick and Erdam’s study (32) included only 
homeless mothers, and Morgenstern et al.’s studies (22, 29, 31) 
analyzed patients receiving welfare [in one study (22), only 
women were included]. Only Essock et al.’s study (20) used high 
service use, severe comorbid mental health disorder, unstable 
housing, and poor living skills as inclusion criteria. Some studies 
even excluded psychotic disorders (22, 24), and Morgenstern 
et  al.’s study (29) excluded patients who had been hospitalized 
more than once for mental health reasons in the past year.
effect of the intervention
Only two studies (28, 30) did not find any additional value in 
CM when treating addicted patients. The other 12 papers found 
significant improvement of some or all the outcome measures. 
These improvements were not the same for each survey.
FigURe 1 | Study flow diagram.
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Five studies showed that substance use decreased (20, 22, 
23, 27, 32), two papers (22, 26) showed that the likelihood of 
initiating SUD treatment increased, and four publications (22, 
23, 27, 33) showed greater treatment retention when a case 
manager was involved in treatment. Four studies (23, 24, 33, 34) 
showed improved access to health care and/or linkage between 
health-care providers. One research showed fewer days spent in 
hospital (20) but others reported an increased number of days 
in hospital, which is explained by the higher treatment reten-
tion (34). Seven publications showed better global functioning, 
which was described as more employment days (25, 31, 35). 
This was further differentiated in Morgenstern et al.’s study of 
2008 (29), which showed that women were more likely than men 
to find employment when assisted by CM, to have fewer legal 
(21, 35) and family problems (21), and to have better housing 
stability (32). Lindahl et al. measured very high patient satisfac-
tion with the treatment and 100% treatment retention compared 
to TAU (23).
DiSCUSSiOn
In most studies, significant improvements were reported in the 
outcome measures. Substance use decreased in only five papers 
(20, 22, 23, 27, 32), but treatment adherence and linkage between 
health-care providers seemed to improve in most surveys, which 
is an important issue for this population and one of the main 
aims of CM. Overall functioning improved in more than half of 
the studies, which is in general linked to higher life satisfaction.
The two publications (28, 30) that did not find significant 
improvements in one of the outcome measures were both per-
formed with incarcerated or paroled patients. In Guydish et al.’s 
paper (30), the important factor was the limited face-to-face time. 
Only 53.6% of participants had seen their CM once or more during 
the first 6 months. For those participants who had seen their CM 
two or more times in the first 6 months, there was an improve-
ment in substance use and social problems. This finding shows 
how important treatment intensity of CM is for the outcome. The 
TABLe 1 | Characteristics of the included studies.
Reference, 
country
Target population number of 
subjects
Control 
intervention
CM interventions/dose of CM Outcome 
measures
Follow-up Results
Guydish et al. 
(30), USA
Drug-involved women 
offenders on probation 
or awaiting probation 
who were willing to 
enter a substance 
abuse treatment 
program
N = 183
IG: n = 92; 
CG: n = 91
TAU = standard 
probation
12 months of PCM involving 
uniform assessment procedures, 
a therapeutic and advocacy 
orientation, treatment planning, 
counseling, and home visits. 
Dosage: at least two contacts per 
month (visit or phone)
ASI, BDI, BSI, 
Social Support 
Evaluation List, 
service utilization, 
arrest during 
12 months of face 
time with CM
6 and 
12 months
Proportion of women enrolled in SUD treatment or incarcerated 
was not statistically different for both groups. All other measures 
were not statistically different between groups. At 6 months, 
53.6% of PCM participants met face-to-face with case manager 
once or more and at 12 months 43.5% did. In CG, this was 11.6 
and 8.5%, respectively. This shows that the dosage was often a 
lot less than twice a month, as described in the intervention. The 
participants who had two or more contacts with case manager 
were more likely to have lower ASI rates and lower social severity 
rates
Essock et al. 
(20), USA
Alcohol and illicit 
drug users with a 
co-occurring major 
psychotic disorder, 
who had high service 
use in the past 2 years, 
were homeless or 
unstably housed, and 
had poor living skills
N = 198
IG: n = 99; 
CG: n = 99
Standard 
clinical CM: 
comprehensive 
assessment, 
individual MI, 
group treatments, 
and stage-wise 
interventions
Three years of community-based 
assertive CM treatment: direct 
substance abuse treatment by 
case managers and comprehensive 
assessment, individual MI, group 
treatments, and stage-wise 
interventions. Case managers had 
half the patient load that they had 
for CG
Substance use 
(days of use, 
ASI, toxicology 
screens) structured 
interview and rating 
scales assessed 
by case manager; 
hospitalization 
rates; Quality of 
Life Interview; CM 
dosage: contacts 
per month with 
case manager
Every 
6 months
Participants in both treatment conditions improved over time 
in multiple outcome domains, and few differences were found 
between the two models. Decreases in substance use were 
greater than would be expected given time alone. At the site 
that had higher rates of institutionalization, clients who received 
standard CM were more likely to be institutionalized. However, in 
the site that had lower rates of institutionalization, no differences 
in the rate of institutionalization were found between the two 
treatment conditions. At one site, the IG received a significantly 
higher dose (time and activities) of services than did the CG. 
At the other site, the difference was not significant. Integrated 
treatment can be successfully delivered either by assertive 
community treatment or by standard clinical CM
Huber et al. 
(21), USA
Drug or alcohol users 
who were diagnosed 
with substance abuse 
disorder and enrolled 
at a substance abuse 
treatment facility
N = 598
IG: n = 437; 
CG: n = 149
Standard drug 
abuse treatment
Community-based comprehensive 
CM intervention: 12 months of 
CM interventions consisted of 
four CM conditions with a case 
manager working as a member 
of drug-treatment staff (inside), 
a case manager from an outside 
social service agency (outside), or a 
case manager using computerized 
telecommunication (telecom). CG 
received standard drug abuse 
treatment. Five types of CM 
interventions were assessing, 
individual solution planning, referral, 
advocating, and conferencing
CM dosage, ASI 3, 6, and 
12 months
Clients who engaged (actively participated) in CM were less 
likely to have legal and family issues, but more likely to have a 
chronic medical condition at baseline. Dosage factors differed 
significantly across treatment conditions. In general, dose was 
significantly related to outcomes in the legal and family domains
(Continued)
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Reference, 
country
Target population number of 
subjects
Control 
intervention
CM interventions/dose of CM Outcome 
measures
Follow-up Results
Lindahl et al. 
(23), Sweden 
(EU)
Court-ordered 
substance abuse 
patients
N = 34
IG: n = 13; 
CG: n = 21
TAU Six months of CM intervention: case 
managers offered assessment, 
transitional care, support of referral 
services, and intervention to avoid 
crisis
Substance use 
(ASI, AUDIT, 
AUDRUG, SIP,  
days of 
alcohol used); 
psychological 
functioning; 
involuntary 
care (coercive 
measures); 
number of days 
in institutional or 
hospital care was 
measured
6 and 
12 months 
after 
discharge
More patients from the CM group were abstinent compared with 
those in the CG at the first follow-up at 6 months (46 vs. 14%, 
p < 0.051).
Patients in the CM group did not have more contact with health 
and social services (92%) compared with those in the CG (76%) 
(p = 0.23), nor did they have more medical-assisted treatment 
(p = 0.46) or institutional/inpatient care (p = 0.27) to a higher 
degree than patients in the CG.
CM interventions were well received by the patients with no 
dropout during intervention. Patients with the support of a case 
manager seemed to sustain abstinence to a higher degree 
compared with TAU, but no differences were detected regarding 
use of care. A subgroup analysis showed that patients with 
continuous drug abuse had access to care from both social 
welfare and hospital care systems
Morgenstern 
et al. (22), 
USA
Women with SUD 
receiving temporary 
assistance for needy 
families; not psychotic, 
under methadone 
treatment or seeking 
methadone treatment, 
or already in treatment 
program
N = 302
IG: n = 161; 
CG: n = 141
TAU, which 
was standard 
substance abuse 
screening and 
referral system 
within welfare 
department
ICM intervention: CM services were 
provided throughout the 15-month 
follow-up period; assessment, 
planning, motivational enhancement, 
treatment coordination, peer 
support, and crisis management. If 
needed, case managers provided 
home visiting services. Contact was 
adapted to needs from daily to two 
visits per month
Substance use 
(ASI, toxicology 
screen). Treatment 
attendance. 
Treatment 
engagement. 
Treatment retention 
rate
3, 9, and 
15 months; 
24 months 
(article 28)
ICM clients had significantly higher levels of substance abuse 
treatment initiation, engagement, and retention compared with 
CG clients. In some cases, ICM treatment attendance rates were 
double those of CG rates. Additionally, almost twice as many 
ICM clients were abstinent at the 15-month follow-up compared 
with CG clients (p < 0.0025). After 24 months, abstinence rates 
were higher in the ICM group than they were for usual care. 
Additionally, there were greater odds of being employed full time
Morgenstern 
et al. (31): 
24-month 
outcome
Morgenstern 
et al. (29), 
USA
SUD welfare applicants 
without acute 
psychotic symptoms 
and not more than 
one hospitalization for 
mental health problems 
in the last year
N = 394 
(66% men)
IG: n = 221; 
CG: n = 173
Usual care CCM: continuity of care intervention 
focused on engaging clients in drug 
treatment, linking to needed ancillary 
services, and fostering transition 
to employment. Biweekly visit at 
treatment center and regular contact 
in office or by phone
Employment 
outcomes (days of 
employment and 
percentage of full-
time employment), 
abstinence 
rates, treatment 
attendance
1-year 
follow-up
Overall, men were more likely to work than women. There 
was no difference between groups. CCM increased women’s 
employment over time. Among women only, greater SUD 
treatment attendance and abstinence in the first 6 months of 
CCM predicted higher rates of later employment
Plater-Zyberk 
et al. (27), 
ON, Canada
Patients enrolled 
in a methadone 
maintenance treatment 
program
N = 1,704
IG: n = 396; 
CG: 
n = 1,308
TAU: standard 
outpatient 
treatment
Clinical CM: duration and frequency 
varied according to clients’ needs
Drug-positive urine 
samples, missed 
daily methadone 
doses, missed 
methadone 
physician 
appointments
3 months The IG demonstrated statistically significant improvement in 
all three measures of the methadone maintenance treatment 
program. Less drug-positive urine: 15.4% relative reduction. 
Fewer missed daily methadone doses: 2% relative reduction. 
Fewer missed appointments with the methadone physician: 40% 
relative reduction
TABLe 1 | Continued
(Continued)
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Reference, 
country
Target population number of 
subjects
Control 
intervention
CM interventions/dose of CM Outcome 
measures
Follow-up Results
Prendergast 
et al. (28), 
USA
Correction population 
who were enrolled 
in a drug-treatment 
program within a 
correctional institution 
(prison, work release, 
community correctional 
facility) in four states
N = 812 
(men and 
women)
IG: n = 412; 
CG: n = 400
Standard referral/
services (SR 
group)
TCM using the SBCM model: 
strengths assessment, conference 
call 1 month prior to release, 
community sessions. After release, 
weekly sessions for 3 months, 
followed by 3 monthly follow-up 
contacts for any client needing 
additional help
SUD treatment 
services, other 
social services, 
drug use, alcohol 
use, arrest, HIV risk 
behavior
3 and 
9 months 
following 
release 
from prison
There were no significant differences between parolees in 
the TCM group and the SR group on outcomes related to 
participation in drug abuse treatment, receipt of social services, 
or drug use, crime, and HIV risk behaviors. For specific services 
(e.g., residential treatment, mental health), although significant 
differences were found for length of participation or for number of 
visits, the number of participants in these services was small and 
the direction of effect was not consistent
Rapp et al. 
(24), USA
Substance abusers 
seeking treatment; not 
psychotic and not only 
alcohol use disorder
N = 678. 
SBCM: 
n = 222
One session 
of MI: 
n = 226; 
CG: n = 230
Standard care 
at a centralized 
intake unit
SBCM: assessing, individual solution 
planning, referral, advocating, and 
conferencing. Up to five sessions 
of SBCM. MI: clarify motivation, 
reinforce treatment-seeking 
behaviors. One 1-h interview
Linkage with SUD 
treatment within 
90 days
3 months SBCM (n = 222) was more effective in improving linkage 
compared to CG (n = 230), 55.0 vs. 38.7%, respectively 
(p < 0.01). SBCM improved linkage more than MI did (55.0 
vs. 44.7%, p < 0.05). MI (n = 226) was not significantly more 
effective in improving linkage than in CG (44.7 vs. 38.7%; 
p > 0.05). The three trial groups differed only slightly on the client 
characteristics that predicted linkage with treatment
Saleh et al. 
(34), USA
Alcohol or drug abuse N = 627 Usual care in 
treatment centers
12 months of CM services in 
community non-profit substance 
abuse treatment centers
Number of 
hospitalization 
days, number of 
ER visits, number 
of physician visits. 
Study 31: legal, 
employment, 
psychiatric 
improvements
3, 6, and 
12 months
IGs showed decrease of the usage of mental health services. 
However, hospital usage, ER visits, and access to physicians 
were increased in IGs. The short duration of CM services was 
expected to increase the use of access outcomes. Study 32: 
legal, employment, and psychiatric improvements
Saleh et al. 
(35)
IG: n = 437 
(treatment 
agency: 
n = 167, 
social 
service 
agency: 
n = 160, 
telecom 
CM: 
n = 147);  
CG: n = 188
Scott et al. 
(33), USA
Substance abuse 
clients who used 
alcohol or other drugs 
in the past 6 months 
and who were 
enrolled in one of nine 
community substance 
abuse treatment 
facilities
N = 692
IG: n = 344; 
CG: n = 348
Usual care in 
community
CM services over a 22-month 
period: assessment, referral 
services, client advocacy, 
counseling, and follow-up treatment
Treatment 
retention, show 
rates to treatment
IG was significantly more likely to show response to treatment 
than CG. No differences found in dose (amount or length of 
substance abuse treatment services) in both IG and CG
TABLe 1 | Continued
(Continued)
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Reference, 
country
Target population number of 
subjects
Control 
intervention
CM interventions/dose of CM Outcome 
measures
Follow-up Results
Siegal et al. 
(25), USA
Veterans seeking 
treatment for 
substance abuse 
problems
N = 632
CM: 
n = 313; 
CG: n = 319
CG: no CM group Veterans in the inpatient component 
participate in three phases lasting a 
total of 28 days. Outpatients attend 
10 weeks of sessions involving 
education about substance abuse 
problems and group therapy 
sessions designed to assist in 
achieving abstinence. Both inpatient 
and outpatient clients are referred 
to an aftercare service upon 
completion of primary treatment. 
The clients in the IG received 
help for strengths assessment, 
identifying goals, and, if appropriate, 
accompaniment on job search
Substance use 
(ASI), psychosocial 
functioning, 
employment 
outcomes
6 months All clients showed significant improvement in employment 
outcomes, an increase of 6 days worked (p < 0.01) in the last 
30 days before the 3-month follow-up. SBCM reported 3.5 
additional days worked compared to non-case-managed clients. 
There was a positive relationship between improved employment 
functioning and improvement in other life areas
Slesnick and 
Erdem (32), 
USA
Substance-abusing 
homeless mothers with 
a 2- to 6-year-old child
N = 60
IG: n = 30; 
CG: n = 30
Usual care in 
community
Ecologically based treatment with 
CM services. The mothers were 
housed in apartments of their 
choosing and received 3 months 
of utility and rental assistance. CM 
services for 6 months, focusing 
on basic needs (i.e., referrals 
to food pantries); assisting, 
obtaining government entitlements; 
employment; connecting to social 
services; providing referrals and/
or transportation to appointments. 
Average of 23.1 sessions in 
6 months
Substance use, 
retention rate, 
independent living 
days
3, 6, and 
9 months
Mothers receiving ecologically based treatment showed a 
high retention rate on treatment, a faster decline in alcohol use 
(p < 0.05), and a faster increase in their independent living days 
(p < 0.001). Furthermore, with supportive services, two-thirds 
of women were successful in maintaining their apartments 
6 months after rental assistance ended. However, no treatment 
effects were found in drug use (p > 0.05)
Strathdee 
et al. (26), 
USA
Clients of the Baltimore 
Needle Exchange 
Program who sought 
drug abuse treatment
N = 245
IG: n = 128; 
CG: n = 117
Passive referral 
[voucher printed 
with date, time, 
and location 
for intake 
appointment 
(of opioid 
agonist) at the 
drug-treatment 
program]
SBCM: engagement, strengths 
assessment, personal case 
planning, resource acquisition. 
The duration and frequency of CM 
contacts were client-driven, based 
on individual desires and needs
Intake appointment 
for opioid agonist 
therapy within 
7 days
7 days In a multivariate “intention-to-treat” model (i.e., ignoring the 
amount of CM actually received), those randomized to CM were 
more likely to enter treatment within 7 days (40 vs. control: 
26%, p = 0.03). Additional “as-treated” analyses revealed that 
participants who received 30 min or more of CM within 7 days 
were 33% more likely to enter treatment. The active ingredient of 
CM activities was provision of transportation
CM, case management; SUD, substance use disorder; IG, intervention group; CG, control group; PCM, probation case management; TAU, treatment as usual; ASI, Addiction Severity Index; BDI, Beck Depression Inventory; BSI, 
Brief Symptom Inventory; AUDIT, Alcohol Use Disorders Identification Test; AUDRUG, Drug Use Identification Test; SIP, Short Index of Problems; ICM, intensive case management; CCM, coordinated care management; SR, standard 
referral; TCM, transitional case management; SBCM, strengths-based case management; MI, motivational interviewing; ER, emergency room.
TABLe 1 | Continued
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other study with a negative outcome, by Prendergast et al. (28), 
showed no improvement in treatment participation for parolees 
with SUD who were receiving CM. However, this finding cannot 
be generalized, as the case manager’s adherence to the protocol 
and the intervention was not standardized. Moreover, the case 
manager seemed to have limited contact with the parolee and the 
parolees did not enroll voluntarily in the project.
The studies are heterogeneous in their clinical approach, which 
limits our ability to generalize specific implications for practice. 
Different types of populations with different risk levels seem to 
account for the variation in readmission rates (36). For example, 
the study populations varied in illness severity (comorbidities 
and service use), which would most likely have an effect on the 
study outcome. Some comorbid populations were also excluded 
from surveys. The CM model is a specific intervention that seems 
more useful to specific subgroups who are unable to use existing 
health-care services. A large number of patients find adequate 
health care in the usual care programs, as shown in research on 
CM interventions that involve psychiatric patients with psycho-
sis. Patients who benefit from CM have been shown to be those 
with greater social and psychosocial needs, more psychiatric 
symptoms, and higher service use (37), with others not needing 
this specific intensive care (38). If CM is applied to a large group, 
the effect on a smaller subgroup would likely be diluted and not 
as visible in the outcome measures. It will be important to further 
specify these subgroups in future in order to refer patients to the 
appropriate programs.
The intensity of application of CM differs in these studies, which 
also limits our ability to generalize the effects (39). These examples 
show the importance of face-to-face time with patients, which can 
be managed only with small caseloads. This seems to have been 
a limiting factor in the two studies (28, 30) mentioned above. In 
addition, the adherence to the model by the case manager and the 
voluntary participation of the patients seem to affect the outcome.
The majority of the studies were performed in the United 
States, which is a limiting factor in generalizing these findings 
to other countries such as those in Europe, where health systems 
differ in organization and funding. A further limitation of this 
research was that the data search was performed only on the 
PubMed database and possibly that unpublished negative studies 
were not taken into account. Furthermore, we did not differenti-
ate between alcohol use disorder and other SUDs.
COnCLUSiOn
Most of the analyzed studies showed improvement in the 
chosen outcome measures, although these varied in different 
studies. Treatment adherence mostly improved, but substance 
use decreased in only a third of the studies. Overall functioning 
improved in about half of the studies. The differences in chosen 
outcome measures make it difficult to compare the results. The 
type of intervention and intensity of treatment also varied.
The heterogeneity of these results might be linked to the dif-
ferent types of populations studied. The specific CM intervention 
seems to be helpful only for specific subpopulations with SUDs. 
Further studies are necessary to determine inclusion criteria for 
CM treatment for patients with SUD in order to orientate those 
most likely to benefit from this approach to the specific CM 
programs.
Only a few studies on this intervention and SUD have been 
published. Further research is needed to examine the effect of 
treatment intensity of the CM intervention. Longitudinal studies 
are also needed in Europe to ensure the effectiveness of these 
treatments.
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